[1] Castilla-Lievre MA,Franco D,Gervais P,et al.Diagnostic value of combining 11 C-choline and 18F-FDG PET/CT in hepatocellular carcinoma. Eur J Nucl Med Mol Imaging,2016,43(5):852-859. [2] 刘东锋旋,张峰旋,潘贤成旋,等. 18F-FDG PET/CT双时相显像在肝癌诊断中的应用价值探讨.实用肝脏病杂志,2016,19(4):463-466. [3] Lee E,Park CM,Kang KW,et al.18F-FDG PET/CT features of pulmonary sclerosing hemangioma. Acta Radiol,2013,54(1):24-29. [4] Ishizaki Y,Kawasaki S.The evolution of liver transplantation for hepatocellular carcinoma (past,present,and future). J Gastroenterol,2008,43:18-26. [5] 李洪生,吴湖炳,王全师,等. 18F -FDG PET/CT在肝癌治疗后AFP升高患者中的应用. 中华核医学与分子影像杂志,2008,28(5):310-312. [6] Mazzaferro V,Regalia E,Doci R et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med,1996,334:693-699. [7] Torte LA,Bray F,Siegel RL,el a1.Global cancer statistics,2012.CA Cancer J Clin,2015,65(2):87-108. [8] Kishida Y,Seki S,Yoshikawa T,et al.Performance comparison between 18F-FDG PET/CT plus brain MRI and conventional staging plus brain MRI in staging of small cell lung carcinoma. Am J Roentgenol,2018,211(1):185-192. [9] Kirimlioglu H,Dvorchick I,Ruppert K,et al.Hepatocellular carcinomas in native livers from patients treated with orthotopic liver transplantation:Biologic and therapeutic implications. Hepatology,2001,34:502-510. [10] 白璐,尚进,刘翔,等. 18F-FDG PET/CT显像对原发性肝癌分化程度和临床分期的评估价值. 实用放射学杂志,2015,31(12):424-417. [11] Teefey SA,Hildeboldt CC,Dehdashti F,et al.Detection of primary hepatic malignancy in liver transplant candidates:Prospective comparison of CT,MR imaging,US,and PET. Radiology,2003,226:533-542. [12] 滕学鹏,孙晓蓉,穆殿斌,等. 胃肝样腺癌18F-FDG PET/CT检查1例. 中华核医学与分子影像杂志,2012,32(4):304-305. [13] Zavaglia C,De Carlis L,Alberti AB,et al.Predictors of long-term survival after liver transplantation for hepatocellular carcinoma. Am J Gastroenterol,2005,100:2708-2716. [14] Lin CY,Chen JH,Liang JA,et al.18F-FDG PET or PET/CT for detecting extrahepatic metastases or recurrent hepatocellular carcinoma:a systematic review and meta-analysis. Eur J Radiol,2012,81(9):2417-2422. [15] 王艳丽,房娜,曾磊,等. 18F-FDG PET/CT对高18F-FDG摄取肝细胞肝癌经动脉插管化疗栓塞的疗效评价. 中华核医学与分子影像杂志,2013,33(5):328-331. [16] Kim SM,Sang SS,Lee BC,et al.Imaging evaluation of ablative margin and index tumor immediately after radiofrequency ablation for hepatocellular carcinoma:comparison between multidetector-row CT and MR imaging. Abdom Radiol (NY),2017,42(10):2527-2537. [17] 贾佳,祁兴顺,韩国宏. 18F-FDGPET/CT评价肝癌预后的价值. 中华消化病与影像杂志(电子版),2014,4(3):33-37. [18] Ma W,Jia J,Wang S,et al.The prognostic value of 18F-FDG PET/CT for hepatocellular carcinoma treated with transarterial chemoembolization (TACE). Theranostics,2014,4(7):736-744. [19] 吴冰,韩磊,姜磊,等. 18F-FDG PET/CT双时相显像在肝细胞肝癌诊断中的应用价值. 中华核医学与分子影像杂志,2014,34(1):58-59. [20] Wang HY,Jeng LB,Lin MC,et al.18F-FDG PET/CT in detection of gynecomastia in patients with hepatocellular carcinoma. Clin Imaging,2013,37(5):942-946. [21] Chan SC,Yeh CH,Yen TC,et al.Clinical utility of simultaneous whole-body 18F-FDG PET/MRI as a single-step imaging modality in the staging of primary nasopharyngeal carcinoma. Eur J Nucl Med Mol Imaging,2018,45(8):1297-1308. [22] Konishi H,Takehara K,Kojima A,et a1.Maximum standardized uptake value of fluorodeoxyglucose positron emission tomography/computed tomography is a prognostic factor in ovarian clear cell adenocarcinoma.Int J Gynecol Cancer,2014,24(7):1190-1194. [23] Su YA,Lee JM,Joo I,et al.Prediction of microvascular invasion of hepatocellular carcinoma using gadoxetic acid-enhanced MR and 18F-FDG PET/CT. Abdom Imaging,2014,40(4):843-851. |